ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,480Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 917

$682K Total Retail Price of All Prescriptions

Rank: 46 out of 917

552 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,669 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 688 614 1 3
OMEPRAZOLE 546 446 2 4
LISINOPRIL 535 454 3 1
WARFARIN SODIUM 444 417 4 10
FUROSEMIDE 394 352 5 7
SIMVASTATIN 360 328 6 2
HYDROCODONE-ACETAMINOPHEN 297 257 S3 7 6
AMLODIPINE BESYLATE 294 288 8 5
LOSARTAN POTASSIUM 289 265 9 13
CITALOPRAM HBR 262 213 10 15
METFORMIN HCL 244 198 11 8
POTASSIUM CHLORIDE 234 212 12 16
HYDROCHLOROTHIAZIDE 231 190 13 9
ATENOLOL 223 200 14 12
GABAPENTIN 220 177 15 17
METOPROLOL TARTRATE 216 198 16 11
ATORVASTATIN CALCIUM 157 144 17 14
PRAVASTATIN SODIUM 152 127 18 20
RANITIDINE HCL 140 95 19 29
ZOLPIDEM TARTRATE 138 114 20 21
ALLOPURINOL 131 124 21 31
LOVASTATIN 124 110 22 19
POLYETHYLENE GLYCOL 3350 117 111 23 66
PANTOPRAZOLE SODIUM 111 98 24 44
MIRTAZAPINE 110 85 25 39
SERTRALINE HCL 109 91 26 24
GLIPIZIDE 99 81 27 40
FLUTICASONE PROPIONATE 96 84 28 26
LANTUS 95 89 29 37
CYMBALTA 91 66 30 56
FENTANYL 90 80 S2 31 58
DONEPEZIL HCL 86 86 32 32
ALENDRONATE SODIUM 81 81 33 23
OXYCODONE-ACETAMINOPHEN 81 63 S2 33 46
FLUOXETINE HCL 81 67 33 38
CYCLOBENZAPRINE HCL 76 50 R 36 65
PROAIR HFA 75 61 37 35
METOPROLOL SUCCINATE 70 70 38 18
CLOPIDOGREL 69 67 39 50
CRESTOR 68 68 40 30
MORPHINE SULFATE ER 66 37 S2 41 48
GLYBURIDE 65 65 R 42 71
FENOFIBRATE 65 45 42 73
AZITHROMYCIN 64 54 44 61
NAMENDA 64 64 44 43
INSULIN SYRINGE 63 40 46 83
CARVEDILOL 61 61 47 33
PRAMIPEXOLE DIHYDROCHLORIDE 60 40 48 137
LANTUS SOLOSTAR 60 52 48 63
PAROXETINE HCL 54 17 50 57
KLOR-CON 10 54 51 50 115
ISOSORBIDE MONONITRATE ER 53 40 52 70
TAMSULOSIN HCL 51 51 53 25
CIPROFLOXACIN HCL 51 46 53 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.